Skip to main navigation
Skip to search
Skip to main content
Region Zealand Home
Help & FAQ
Link opens in a new tab
Dansk
English
Search content at Region Zealand
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Courses
Press/Media
Impacts
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
Sebastian Weis
*
, Annegret Franke
, Joachim Mössner
, Janus C. Jakobsen
, Konrad Schoppmeyer
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review
›
Research
›
peer-review
Overview
Fingerprint
Fingerprint
Explore the research areas of 'Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma'.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Hepatectomy
100%
Hazard Ratio
85%
Overall Survival
71%
Placebo
57%
Acetic Acid
57%
Liver Transplantation
57%
Randomized Clinical Trial
42%
Percutaneous Ethanol Injection
42%
Sequential Analysis
28%
Event Free Survival
28%
Subgroup Analysis
14%
Malignant Neoplasm
14%
Recurrent Disease
14%
Adverse Event
14%
Laser Surgery
14%
Microwave Thermotherapy
14%
Interventional Therapy
14%
Odds Ratio
14%
Keyphrases
Hepatocellular Carcinoma
100%
Radiofrequency Thermocoagulation
100%
Confidence Interval
30%
Hepatic Resection
26%
Hazard Ratio
23%
Risk of Bias
23%
Overall Survival
19%
Placebo
15%
Low Risk
15%
Acetic Acid
15%
Liver Transplantation
15%
Randomized Clinical Trial
11%
Risk Ratio
11%
Ethanol
11%
Percutaneous Ethanol Injection
11%
Acid Injection
11%
Clinical Analysis
7%
Random Error
7%
Therapeutic Approaches
7%
Event-free Survival
7%
High Risk
3%
Chemotherapy
3%
Adverse Events
3%
Subgroup Analysis
3%
Survival Outcomes
3%
Data Extraction
3%
Embase
3%
Cochrane
3%
Harmful Effects
3%
Odds Ratio
3%
MEDLINE
3%
Beneficial Effects
3%
Number of Participants
3%
Risk Assessment
3%
Review Authors
3%
Cochrane Central Register of Controlled Trials
3%
Hospital Stay
3%
Publication Status
3%
Hepatobiliary
3%
Potential Harm
3%
AASLD
3%
Local Recurrence
3%
Potential Gains
3%
Overall Risk
3%
Statistical Significance
3%
Common Cancers
3%
Surgical Resection
3%
Major Complications
3%
Selection Criteria
3%
Search Methods
3%
Ablation
3%
Hepatocellular Carcinoma Patients
3%
ISI Web of Science
3%
Chemotherapeutic Treatment
3%
Early Hepatocellular Carcinoma
3%
Local Progression
3%
Interventional Techniques
3%
Principal Investigator
3%
Asco
3%
Sparse Data
3%
Acid Groups
3%
Effect Measure
3%
Microwave Ablation
3%
Language Status
3%
Meeting Abstracts
3%
Laser Ablation
3%
APASL
3%
Surgically Treated
3%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Liver Cell Carcinoma
100%
Placebo
80%
Potassium Acetate
80%
Randomized Clinical Trial
60%
Event Free Survival
40%
Chemotherapy
20%
Recurrent Disease
20%
Adverse Event
20%
Malignant Neoplasm
20%
Biochemistry, Genetics and Molecular Biology
Radiofrequency
100%
Overall Survival
19%
Acetic Acid
15%
Randomized Clinical Trial
11%
Event Free Survival
7%
Cochrane Library
3%
Web of Science
3%
Data Extraction
3%